Artificial Cells, Blood Substitutes, and Biotechnology This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.
Zingiberis rhizoma-based carbon dots alter serum oestradiol and follicle-stimulating hormone levels in female mice
Volume 52, Issue 1, December 2024, Page 12-22 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - November 23, 2023 Category: Biotechnology Authors: Yumin ChenXue BaiYing ZhangYafang ZhaoHuagen MaYunbo YangMeijun WangYinghui GuoXiaopeng LiTong WuYue ZhangHui KongYan ZhaoHuaihua Qua School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, Chinab School of Chinese Materia Source Type: research
HBOC alleviated tumour hypoxia during radiotherapy more intensely in large solid tumours than regular ones
Volume 52, Issue 1, December 2024, Page 1-14 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - November 23, 2023 Category: Biotechnology Authors: Yingcan XuKehui ZhuJiakang WuShifan ZhengRui ZhongWentao ZhouYe CaoJiaxin LiuHong WangInstitute of Blood Transfusion, Chinese Academy of Medical Sciences, Peking Union Medical College, Chengdu, China Source Type: research
Zingiberis rhizoma-based carbon dots alter serum oestradiol and follicle-stimulating hormone levels in female mice
Volume 52, Issue 1, December 2024, Page 12-22 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - November 23, 2023 Category: Biotechnology Authors: Yumin ChenXue BaiYing ZhangYafang ZhaoHuagen MaYunbo YangMeijun WangYinghui GuoXiaopeng LiTong WuYue ZhangHui KongYan ZhaoHuaihua Qua School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, Chinab School of Chinese Materia Source Type: research
HBOC alleviated tumour hypoxia during radiotherapy more intensely in large solid tumours than regular ones
Volume 52, Issue 1, December 2024, Page 1-14 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - November 23, 2023 Category: Biotechnology Authors: Yingcan XuKehui ZhuJiakang WuShifan ZhengRui ZhongWentao ZhouYe CaoJiaxin LiuHong WangInstitute of Blood Transfusion, Chinese Academy of Medical Sciences, Peking Union Medical College, Chengdu, China Source Type: research
Zingiberis rhizoma-based carbon dots alter serum oestradiol and follicle-stimulating hormone levels in female mice
Volume 52, Issue 1, December 2024, Page 12-22 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - November 23, 2023 Category: Biotechnology Authors: Yumin ChenXue BaiYing ZhangYafang ZhaoHuagen MaYunbo YangMeijun WangYinghui GuoXiaopeng LiTong WuYue ZhangHui KongYan ZhaoHuaihua Qua School of Traditional Chinese Medicine, Beijing University of Chinese Medicine, Beijing, Chinab School of Chinese Materia Source Type: research
Process-structure-biofunctional paradigm in cellular structured implants: an overview and perspective on the synergy between additive manufacturing, bio-mechanical behaviour and biological functions
Volume 51, Issue 1, December 2023, Page 630-640 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - November 7, 2023 Category: Biotechnology Authors: R. D. K. MisraK. P. Misraa Department of Metallurgical, Materials and Biomedical Engineering and Biomedical and Biomaterials Research Laboratory, Center for Structural and Functional Materials, University of Texas at El Paso, El Paso, Texas, USAb Departme Source Type: research
Advances in screening and diagnostic lab-on-chip tools for gynaecological cancers – a review
Volume 51, Issue 1, December 2023, Page 618-629 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - November 7, 2023 Category: Biotechnology Authors: Sadeka NujhatHannah S. LeeseMirella Di LorenzoRebecca BowenSandhya Moisea Department of Chemical Engineering, University of Bath, Bath, UKb Centre for Bioengineering and Biomedical Technologies (CBio), University of Bath, Bath, UKc Royal United Hospitals Source Type: research
Niosomes gel of apigenin to improve the topical delivery: development, optimization, ex vivo permeation, antioxidant study, and in vivo evaluation
Volume 51, Issue 1, December 2023, Page 604-617 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - November 1, 2023 Category: Biotechnology Authors: Omar Awad AlsaidanAmeeduzzafar ZafarRayan Hamood Al-RuwailiMohd YasirSami I. AlzareaAseel Awad AlsaidanLubhan SinghMohammad Khalida Department of Pharmaceutics, College of Pharmacy, Jouf University, Sakaka, Al-Jouf, Saudi Arabiab Department of Pharmacy, C Source Type: research
A study on the therapeutic potential of graphene titanate nanocomposite for treating chemically induced arthritis in rats
Volume 51, Issue 1, December 2023, Page 590-603 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - October 30, 2023 Category: Biotechnology Authors: Amany BelalMohamed Y. ZakyDoaa S. MohamedEman E. MohamedRehab MahmoudDoaa EssamR. R. AttaFatma I. Abo El-ElaFatma Mohamed HalfayaKyung-Tae LeeAhmed H.E HassanMohammed M. GhoneimAhmed Farghalia Department of Pharmaceutical Chemistry, College of Pharmacy, T Source Type: research
Cancer reduction in mice with Prakasine nanomedicine immunotherapy
Volume 51, Issue 1, December 2023, Page 572-589 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - October 26, 2023 Category: Biotechnology Authors: Prakash S.KNaval AIDS Research Centre, Namakkal, Tamil Nadu, India Source Type: research
Statement of retraction: Anti-gastric cancer effect of Salidroside through elevating miR-99a expression
Volume 51, Issue 1, December 2023, Page 548-548 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - October 23, 2023 Category: Biotechnology Source Type: research
Statement of retraction: Mirt2 functions in synergy with miR-377 to participate in inflammatory pathophysiology of Sj ögren’s syndrome
Volume 51, Issue 1, December 2023, Page 547-547 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - October 23, 2023 Category: Biotechnology Source Type: research
Ultrasound-triggered release of miR-199a-3p from liposome nanobubbles for enhanced hepatocellular carcinoma treatment
Volume 51, Issue 1, December 2023, Page 560-571 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - October 18, 2023 Category: Biotechnology Authors: Xinmin GuoJianru LinLiwen PanKun HeZhihui HuangJialin ChenCuiyan LinBaohui ZengSijia LuoMengdie Wanga Department of Ultrasound, Guangzhou Red Cross Hospital of Jinan University, Guangzhou, Chinab Department of Endocrinology, Guangzhou Red Cross Hospital o Source Type: research
Green synthesis, characterisation and antibacterial activities of Strobilanthes crispus-mediated silver nanoparticles (SC-AGNPS) against selected bacteria
Volume 51, Issue 1, December 2023, Page 549-559 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - October 17, 2023 Category: Biotechnology Authors: Rohazila Mohamad HanafiahSiti Aisyah Abd GhafarVuanghao LimSiti Nor Asma MusaFahmi YakopArif Haikal Hairil Anuara Department of Basic Science, Faculty of Dentistry, Universiti Sains Islam Malaysia, Ampang Kuala Lumpur, Malaysiab Integrative Medicine Clust Source Type: research
Study on tumour cell-derived hybrid exosomes as dasatinib nanocarriers for pancreatic cancer therapy
Volume 51, Issue 1, December 2023, Page 532-546 . (Source: Artificial Cells, Blood Substitutes, and Biotechnology)
Source: Artificial Cells, Blood Substitutes, and Biotechnology - October 5, 2023 Category: Biotechnology Authors: Xiaofei ZhouYuetang ZhuangXiaohong LiuYaowen GuJunting WangYuchen ShiLi ZhangRui LiYelin ZhaoHebing ChenJiao LiHongjuan YaoLiang Lia Key Laboratory of Antibiotic Bioengineering of National Health and Family Planning Commission (NHFPC), Institute of Medici Source Type: research